You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 22, 2025

Drug Price Trends for NDC 49348-0181


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 49348-0181

Drug Name NDC Price/Unit ($) Unit Date
SM WITCH HAZEL 86% SOLUTION 49348-0181-38 0.00695 ML 2025-03-19
SM WITCH HAZEL 86% SOLUTION 49348-0181-38 0.00692 ML 2025-02-19
SM WITCH HAZEL 86% SOLUTION 49348-0181-38 0.00702 ML 2025-01-22
SM WITCH HAZEL 86% SOLUTION 49348-0181-38 0.00700 ML 2024-12-18
SM WITCH HAZEL 86% SOLUTION 49348-0181-38 0.00724 ML 2024-11-20
SM WITCH HAZEL 86% SOLUTION 49348-0181-38 0.00687 ML 2024-10-23
SM WITCH HAZEL 86% SOLUTION 49348-0181-38 0.00668 ML 2024-09-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 49348-0181

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 49348-0181: Sunmark Witch Hazel

Introduction

The pharmaceutical industry is a complex and dynamic market, influenced by various factors including regulatory changes, competition, and technological advancements. This article focuses on the market analysis and price projections for the drug identified by the National Drug Code (NDC) 49348-0181, which corresponds to Sunmark Witch Hazel, a product manufactured and distributed by McKesson.

Understanding NDC 49348-0181

NDC 49348-0181 is associated with Sunmark Witch Hazel, a product used for various skin care and medicinal purposes. This NDC is part of the broader catalog of products managed by McKesson, a significant player in the pharmaceutical distribution sector[1].

Market Trends in the Pharmaceutical Industry

The pharmaceutical industry is experiencing several key trends that could impact the pricing and market dynamics of products like Sunmark Witch Hazel.

Digital Transformation and Innovation

The life sciences industry is undergoing significant digital transformation, which is expected to drive operational efficiencies and innovation. This trend, highlighted in Deloitte's 2025 life sciences outlook, suggests that companies leveraging digital technologies, including AI and data analytics, will have a competitive edge[3].

Pricing and Access

Pricing and access to drugs remain critical issues in the industry. Nearly half of the C-suite executives surveyed by Deloitte expect pricing and access to significantly affect their strategies in 2025. This could influence the pricing strategies for over-the-counter (OTC) products like Sunmark Witch Hazel[3].

Competition from Generics and Biosimilars

The rise of generic drugs and biosimilars is another significant trend. With many high-revenue products facing patent expirations, the market is likely to see increased competition from generic and biosimilar alternatives. However, since Sunmark Witch Hazel is an OTC product, it may be less directly impacted by these trends[3].

Pricing Dynamics

Current Pricing

The pricing of Sunmark Witch Hazel is not explicitly listed in the sources provided, but it can be inferred that the product's price is influenced by market demand, production costs, and regulatory factors.

Historical Pricing Context

For other products listed under the same NDC labeler (McKesson), prices can vary widely based on the specific product and market conditions. For example, prices for other McKesson products have shown fluctuations over time, reflecting changes in market conditions and regulatory environments[1].

Future Price Projections

Given the general trends in the pharmaceutical industry, here are some potential factors that could influence the future pricing of Sunmark Witch Hazel:

  • Market Demand: If demand for witch hazel products increases due to growing consumer interest in natural health products, prices could rise.
  • Regulatory Changes: Any changes in regulatory requirements or standards could impact production costs and, subsequently, the price of the product.
  • Competition: Increased competition from other OTC products or natural remedies could pressure prices downward.

Regulatory Considerations

The FDA's National Drug Code Directory provides insights into how products are listed and delisted. For Sunmark Witch Hazel, the marketing start and end dates are crucial. If the product is delisted, it would no longer be in commercial distribution, affecting its price and availability[5].

Industry Outlook

Growth and Innovation

The overall prescription drug market is expected to grow at a CAGR of 9% through 2030, driven by innovation and digital transformation. While this growth is more relevant to prescription drugs, it indicates a broader trend of increased investment and innovation in the healthcare sector, which could indirectly benefit OTC products like Sunmark Witch Hazel[4].

Patient-Centric Approaches

The life sciences industry is shifting towards more patient-centric approaches, including personalized medicine. While this is more relevant to prescription drugs, it reflects a broader industry trend towards more tailored and effective healthcare solutions, which could influence consumer preferences and demand for OTC products[3].

Key Takeaways

  • Market Trends: Digital transformation, pricing and access issues, and competition from generics and biosimilars are key trends in the pharmaceutical industry.
  • Pricing Dynamics: Prices for Sunmark Witch Hazel will be influenced by market demand, production costs, and regulatory factors.
  • Regulatory Considerations: The FDA's NDC Directory and any changes in regulatory requirements will impact the product's availability and pricing.
  • Industry Outlook: The overall growth and innovation in the healthcare sector could indirectly benefit OTC products.

FAQs

What is the NDC 49348-0181 associated with?

NDC 49348-0181 is associated with Sunmark Witch Hazel, a product manufactured and distributed by McKesson.

How does the pharmaceutical industry's digital transformation impact OTC products?

The digital transformation in the pharmaceutical industry can drive operational efficiencies and innovation, which may indirectly benefit OTC products by improving distribution, marketing, and consumer engagement.

What are the key factors influencing the price of Sunmark Witch Hazel?

The price of Sunmark Witch Hazel is influenced by market demand, production costs, regulatory factors, and competition from other OTC products.

How does the rise of generics and biosimilars affect OTC products?

The rise of generics and biosimilars primarily affects prescription drugs but can indirectly influence the market dynamics of OTC products by changing consumer preferences and expectations.

What is the expected growth rate of the prescription drug market through 2030?

The prescription drug market is expected to grow at a CAGR of 9% through 2030, driven by innovation and digital transformation[4].

Sources

  1. Find-A-Code: McKesson - List of Drugs - NDC Labeler/Manufacturer.
  2. NADAC Pricing Alphabetical NDC Index: Complete listing table of the most recent wholesale prices for NDC Codes.
  3. Deloitte Insights: 2025 life sciences outlook.
  4. DrugPatentWatch: Latest drug prices and trends for NDC 00054-0319.
  5. FDA: National Drug Code Directory.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.